Document is current
Any future updates will be listed below
-
Authors
Lehodey, Asrar
Kaliman, Perla
Palix, Cassandre
de Florès, Robin
Touron, Edelweiss
Turpin, Anne-Laure
Fauvel, Séverine
Mézenge, Florence
Landeau, Brigitte
Chocat, Anne
Vrillon, Agathe
Paquet, Claire
Vivien, Denis
de La Sayette, Vincent
Chételat, Gaël
Poisnel, Géraldine
,
André, Claire
Arenaza-Urquijo, Eider M.
Champetier, Pierre
Colette, Fabienne
De Flores, Robin
Delarue, Marion
Felisatti, Francesca
Devouge, Egantine Ferrand
Garnier-Crussard, Antoine
Gonneaud, Julie
Heidmann, Marc
Jessen, Frank
Klimecki, Olga
Kuhn, Elizabeth
Le Du, Gwendoline
Lefranc, Valérie
Lutz, Antoine
Marchant, Natalie
Mezenge, Florence
Moulinet, Inès
Ourry, Valentin
Paly, Léo
Poletti, Stefano
Quillard, Anne
Rauchs, Géraldine
Rehel, Stéphane
Salmon, Eric
Sherif, Siya
Vanhoutte, Matthieu
Vuilleumier, Patrik
Ware, Caitliin
Wirth, Miranka
- License Information
-
More Information
Article History
Received: 11 September 2024
Accepted: 2 December 2024
First Online: 20 December 2024
Declarations
:
: All participants gave their written informed consent to participate in the study. The Age-Well RCT, sponsored by Institut National de la Santé et de la Recherche Médicale (INSERM), was approved by the ethics committee (CPP Nord-Ouest III, Caen).
: Dr Chételat reported receiving grants, personal fees, and nonfinancial support from the Institut National de la Santé et de la Recherche Médicale (INSERM), as well as grants from the European Union's Horizon 2020 Research and Innovation Program (grant 667696) during the conduct of the study and grants and personal fees from Fondation Entrepreneurs MMA and Fondation Alzheimer and grants from MMA and Région Normandie outside the submitted work. Dr Poisnel reported grants and nonfinancial support from INSERM grants from European Union's Horizon 2020 Research and Innovation Program [grant 667696] during the conduct of the study and grants from Région Normandie, Ministry of Higher Education and Research and INSERM outside the submitted work; and has participated in the data safety monitoring board of the Age-Well trial and to the executive committee of Medit-Ageing. No other disclosures were reported.
